The CD47 Targeting Therapeutics Market is witnessing a paradigm shift, poised for explosive growth over the next decade. A recent analysis indicates that the market size will escalate from USD 2.41 billion in 2024 to an astounding USD 23.3 billion by 2035, reflecting a remarkable CAGR of 22.89%. This growth trajectory can largely be attributed to the increasing prevalence of cancer, with over...